Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Vir names David Liu chief medical officer effective Oct. 12, 2026

Vir names David Liu chief medical officer effective Oct. 12, 2026

BitgetBitget2026/10/07 12:31

Vir Biotechnology named David Liu executive vice president, chief medical officer, effective Oct. 12, 2026. Liu will lead clinical development, medical affairs, regulatory affairs as Vir advances its Phase 3 chronic hepatitis delta program. He joins from Nuvation Bio, where he served as CMO and built its global clinical R&D organization. Liu previously served as CMO of 3D Medicines. Earlier roles include executive medical director at Celgene, leadership posts at Bristol Myers Squibb, scientist at AstraZeneca. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610070830BIZWIRE_USPR_____20261007_BW701943) on October 07, 2026, and is solely responsible for the information contained therein.

  • Vir Biotechnology named David Liu executive vice president, chief medical officer, effective Oct. 12, 2026.
  • Liu will lead clinical development, medical affairs, regulatory affairs as Vir advances its Phase 3 chronic hepatitis delta program.
  • He joins from Nuvation Bio, where he served as CMO and built its global clinical R&D organization.
  • Liu previously served as CMO of 3D Medicines.
  • Earlier roles include executive medical director at Celgene, leadership posts at Bristol Myers Squibb, scientist at AstraZeneca.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610070830BIZWIRE_USPR_____20261007_BW701943) on October 07, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high

Japan's spot electricity prices surged to multi-year highs over the weekend.

智通财经•2026/11/09 08:07
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high

Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail

Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

智通财经•2026/11/09 07:32
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail